Niti Aayog, USAID collaborate to improve healthcare in India

The USAID, IPE Global, and stakeholders from the government, academia, and the private sector developed the SAMRIDH blended finance facility in 2020

February 9, 2022

AIM, NITI Aayog, and USAID’s partnership under SAMRIDH initiative looks to improve access to affordable healthcare for the country’s most vulnerable populations

The focus of this partnership is to mount an effective response to the ongoing third wave of the pandemic

The collaboration would also look at building health system readiness

Blended financing can enable partnerships that open greater pools of affordable capital for scaling-up businesses that deliver both financial and social returns: Amitabh Kant

The Atal Innovation Mission (AIM), NITI Aayog, and the US Agency for International Development (USAID) announced a new partnership under the Sustainable Access to Markets and Resources for Innovative Delivery of Healthcare (SAMRIDH) initiative, to improve access to affordable and quality healthcare for vulnerable the population in tier-2 and tier-3 cities, and rural and tribal areas.

The focus of this partnership would traverse the healthcare landscape with the common goal to mount an effective response to the ongoing third wave of the pandemic. The collaboration would also look at building health system readiness for future infectious disease outbreaks and health emergencies.

The USAID, IPE Global, and other stakeholders from the government, academia, and the private sector developed the SAMRIDH blended finance facility in 2020 with an aim to combine public and philanthropic funds to create and rapidly scale market-based health solutions by leveraging AIM’s expertise in innovation and entrepreneurship. NITI Aayog’s CEO Amitabh Kant also stated that blended financing can enable partnerships that open greater pools of affordable capital for scaling-up businesses that deliver both financial and social returns.

Recent Articles

Indian MNCs to add 500 GCCs by 2026: Nasscom

November 29, 2022

Indian Multinational Companies (MNCs) are expected to add over 500 …

Read More

Projected Q2 GDP to reach 6.5%

November 28, 2022

India’s economic growth is seen to have moderated in the …

Read More

Pharma exports up by 138% in April-Oct FY23 from FY14

November 25, 2022

India’s pharma exports have increased by 138% to INR 90,324.23 …

Read More